semaglutide long-term affordability

semaglutide long-term affordability

What Industry Insiders Warn About Prescription Weight Loss Costs

What Industry Insiders Warn About Prescription Weight Loss Costs In 2023, GLP-1 drugs such as semaglutide rose to become the 157th most prescribed medication in the United States, with over 3 million prescriptions, yet industry insiders warn that insurance coverage is lagging, leaving patients to shoulder lifelong costs. Medical Disclaimer: